NUE Life Health Inc.

Nue Life Health Inc. is a U. S. -based company that specializes in at-home ketamine therapy, aimed at addressing mental health conditions such as depression and anxiety through innovative treatment solutions.

Founded in 2021, Nue Life Health Inc. operates from Miami Beach, US, focusing on mental health therapies. The company has engaged in 7 deals, with the latest funding round occurring on October 26, 2023, with an investment of USD 1. 90 mn from Myelin VC and Obvious Ventures.

The CEO, Dan Love, alongside founder Jp Cappello, leads the company. Nue Life primarily offers at-home ketamine therapy tailored for mental health conditions, including treatment-resistant depression and PTSD. Their structured program, "Nue Reset," provides a holistic approach with multiple ketamine treatments supported by an interactive mobile app for real-time communication with healthcare professionals and ongoing support. Nue Life's revenue model centers around direct-to-consumer sales of their treatment programs, priced at USD 1,399 for the "Nue Reset" package, which includes a series of ketamine treatments, medical consultations, and integration support.

This model ensures continuous client engagement and retention, contributing to their revenue stream in the mental wellness market. Nue Life aims to expand its offerings by developing new ketamine-assisted therapy products, with plans to enter additional geographical regions. Recent funding will support these initiatives, particularly in enhancing their therapeutic programs. They are poised to leverage their acquisition of Beckley Waves Ltd to advance their treatment methodologies.